I. H. Park

A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer

Kyong Hwa Park, Joohyuk Sohn, Seoul Lee et al. · Investigational New Drugs · 2013 · 25 citations · Full text

Medicine, Oncology, Pharmacology +13

CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma

S-E. Chang, I. H. Park, Jooryung Huh et al. · British Journal of Dermatology · 2000 · 22 citations

Medicine, Dermatology, Pathology +11

A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer

Kyong Hwa Park, Seoul Lee, Jin‐hong Park et al. · Supportive Care in Cancer · 2016 · 13 citations · Full text

Medicine, Oncology, Pharmacology +11